← Leaderboards
Rachel Hannah Kravitz
Neoclone Biotechnology International
$589,533
Attributed
$716,594
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $286.4K · FY2007–12$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$716,594 · 4
By mechanism
R43$526,003 · 3
R41$190,591 · 1
Top collaborators
- Joseph P Connor1 shared
- Manish S Patankar1 shared
Most similar at Neoclone Biotechnology International
Same institution · by research overlap
- Joseph P Connor$160,427
Others in their field
Top investigators on “Affinity”
- Dennis R. Burton · Scripps Research Institute$64,397,776
- James E Crowe · Vanderbilt University Medical Center$53,471,415
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$45,445,140
- Timothy A Springer · Boston Children'S Hospital$41,593,445
- Misty Ward Stevens · Intervexion Therapeutics, Llc$38,187,594
- Rafi Ahmed · Emory University$36,776,987
Research focus
AffinityAntigensCellsAntibodiesTechnologyMonoclonal AntibodiesImmunizationMarketingPharmaceutical PreparationsCancer TherapyIn VitroMalignant NeoplasmsGrowthImmunoglobulinsBiotechnologyEvaluationB-LymphocytesCytokineCostAntigen TargetingGovernmentImmune ResponseBaseInternational
Grant awards (4)
Reactivation of human cells for novel fully human Ab platform$286,368
R43 · FY2012 · CA · contact PI
Improving Ovarian Cancer Treatment by Targeting a Novel Epitope of MUC16$190,591
R41 · FY2009 · CA · contact PI
Novel Platform Technology for Developing Therapeutic Human mAbs$140,000
R43 · FY2007 · CA · contact PI
A novel platform for mining the repertoire of antigen-specific B cells$99,635
R43 · FY2007 · CA · contact PI